EP2679681

CHUGAI SEIYAKU KABUSHIKI KAISHA
Application Number
EP12749420A
Filing Date
Feb 24, 2012
Status
Patent Maintained As Amended
Oct 13, 2023
Grant Date
Nov 15, 2023
External Links
Slate, Register

Biblio Summary

The patent EP2679681B2 was granted on Nov 15, 2023 by Chugai Seiyaku Kabushiki Kaisha The patent is currently Patent Maintained As Amended.

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

HGF LIMITEDMay 6, 2020ADMISSIBLE

The table below shows the patents of Chugai Seiyaku Kabushiki Kaisha that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3296395Multiple Antigen Binding Molecular Fusion, Pharmaceutical Composition, Method For Identifying Linear Epitope, And Method For Preparing Multiple Antigen Binding Molecular FusionJun 19, 20241
EP3815688Pharmaceutical Composition Containing Poorly-Soluble Basic MedicineDec 6, 20232
EP3320773Non-Human Animal Having Human Cd3 Gene Substituted For Endogenous Cd3 GeneOct 11, 20231